These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9108396)

  • 1. Human platelets as a model for the binding and degradation of thrombopoietin.
    Fielder PJ; Hass P; Nagel M; Stefanich E; Widmer R; Bennett GL; Keller GA; de Sauvage FJ; Eaton D
    Blood; 1997 Apr; 89(8):2782-8. PubMed ID: 9108396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
    Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ
    Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelets display high-affinity receptors for thrombopoietin.
    Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K
    Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.
    Scheding S; Bergmann M; Shimosaka A; Wolff P; Driessen C; Rathke G; Jaschonek K; Brugger W; Kanz L
    Transfusion; 2002 Mar; 42(3):321-7. PubMed ID: 11961237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
    Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
    Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
    Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
    Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of biological activity and inhibition of receptor binding by antibodies against human thrombopoietin.
    Tahara T; Kuwaki T; Matsumoto A; Morita H; Watarai H; Inagaki Y; Ohashi H; Ogami K; Miyazaki H; Kato T
    Stem Cells; 1998; 16(1):54-60. PubMed ID: 9474748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice.
    Stefanich E; Senn T; Widmer R; Fratino C; Keller GA; Fielder PJ
    Blood; 1997 Jun; 89(11):4063-70. PubMed ID: 9166846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
    Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
    Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
    Broudy VC; Lin NL
    Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.